Skip to main content

Advertisement

SpringerLink
Log in

The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues

  • Research Article
  • Published:
Tumor Biology

Abstract

The purpose of this study was to detect the expression of autophagy-related gene Beclin1 and apoptosis-related genes Bcl-2 and Bax in breast cancer tissues, to investigate their relationship and significance to the occurrence and development of breast cancer, and to provide an experimental basis for the biological treatment of breast cancer in the future. Human breast cancer tissues and relatively healthy breast tissue adjacent to the tumor were collected during surgical resection. By using RT–PCR and western blot, the mRNA and protein expressions of Beclin1, Bcl-2, and Bax were detected in the breast cancer tissues and the relatively healthy, adjacent tissues. The correlations of these expressions with the occurrence, development, and clinicopathology of breast cancer were analyzed. The mRNA and protein expressions of Beclin1 and Bcl-2 in breast cancer tissues were significantly lower than those in the relatively healthy, adjacent breast tissues (p < 0.05); the lower the degree of tumor differentiation, the lower the mRNA and protein expressions of Beclin1 and Bcl-2 (p < 0.05); the mRNA and protein expressions of Beclin1 and Bcl-2 in breast cancer tissues from patients positive for lymph node metastasis were significantly lower than those negative for lymph node metastasis (p < 0.05); the mRNA and protein expressions of Beclin1 and Bcl-2 in breast cancer tissues from patients positive for distant metastasis were significantly lower than those negative for distant metastasis (p < 0.05); the mRNA and protein expressions of Beclin1 and Bcl-2 in breast cancer tissues from patients positive for ki67 were significantly lower than those negative for ki67 (p < 0.05). The mRNA and protein expressions of Bax were different from those of Beclin1 and Bcl-2. In breast cancer tissues, the mRNA and protein expressions of Bax were up-regulated (p < 0.05); the lower the degree of tumor differentiation, the higher the mRNA and protein expressions of Bax (p < 0.05); the mRNA and protein expressions of Bax in breast cancer tissues from patients positive for lymph node metastasis were significantly higher than those negative for lymph node metastasis (p < 0.05); and the mRNA and protein expressions of Bax in breast cancer tissues from patients positive for distant metastasis were significantly higher than those in patients negative for distant metastasis (p < 0.05). However, the mRNA and protein expressions of these three genes were not correlated with patient age, tumor size, progesterone receptor positivity, or human epidermal growth factor positivity (p > 0.05). The correlation of Bcl-2 and Bax mRNA with Beclin1 mRNA expressed in breast cancer tissues were both statistically significant (p < 0.05). The activity change of autophagy and apoptosis is associated with the tumorigenesis and tumor progression of breast cancer. The joint detection of these three genes (Beclin1, Bcl-2, and Bax) contributes to the early diagnosis of and predicts prognosis for breast cancer, and this also provides an experimental basis for the biological therapy of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Luedders DW, von Tengg-Kobligk H, Hornemann A, et al. Current diagnostic modalities and clinical pitfalls in malignant secondary breast tumours. Arch Gynecol Obstet. 2011 [Epub ahead of print]

  2. Xu YL, Sun Q. Headway in resistance to endocrine therapy in breast cancer. J Thorac Dis. 2010;2:171–7.

    CAS  Google Scholar 

  3. Grander D, Panaretakis T. Autophagy: cancer therapy's friend or foe? Future Med Chem. 2010;2:285–97.

    Article  PubMed  CAS  Google Scholar 

  4. Rodriguez-Rocha H, Garcia-Garcia A, Panayiotidis MI, et al. DNA damage and autophagy. Mutat Res. 2011 [Epub ahead of print]

  5. Li J, Ni M, Lee B, et al. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death Differ. 2008;15:1460–71.

    Article  PubMed  CAS  Google Scholar 

  6. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science. 2004;306:990–5.

    Article  PubMed  CAS  Google Scholar 

  7. Tanida I. Autophagy basics. Microbiol Immunol. 2011;55:1–11.

    Article  PubMed  CAS  Google Scholar 

  8. Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672–6.

    Article  PubMed  CAS  Google Scholar 

  9. Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics. 1999;59:59–65.

    Article  PubMed  CAS  Google Scholar 

  10. Kihara A, Kabeya Y, Ohsumi Y, et al. Beclin–phosphatidylinositol 3–kinase complex functions at the trans-Golgi network. EMBO Rep. 2001;2:330–5.

    Article  PubMed  CAS  Google Scholar 

  11. Meschini S, Condello M, Lista P, et al. Autophagy: molecular mechanisms and their implications for anticancer therapies. Curr Cancer Drug Targets. 2011;11:357–79.

    Article  PubMed  CAS  Google Scholar 

  12. Chen N, Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther. 2011;11:157–68.

    Article  PubMed  CAS  Google Scholar 

  13. Stojanovic A, Cerwenka A. Natural killer cells and solid tumors. J Innate Immun. 2011;3:355–64.

    Article  PubMed  Google Scholar 

  14. Ogbomo H, Cinatl Jr J, Mody CH, et al. Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy. Trends Mol Med. 2011;17:433–41.

    Article  PubMed  CAS  Google Scholar 

  15. Olsson M, Zhivotovsky B. Caspases and cancer. Cell Death Differ. 2011 [Epub ahead of print]

  16. Yang H, Dou QP. Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. Curr Drug Targets. 2010;11:733–44.

    Article  PubMed  CAS  Google Scholar 

  17. Thomadaki H, Scorilas A. Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs. Connect Tissue Res. 2008;49:261–4.

    Article  PubMed  CAS  Google Scholar 

  18. Szende B. The occurrence and significance of apoptosis in tumors. Magy Onkol. 2004;48:215–9.

    PubMed  Google Scholar 

  19. Sarkar FH, Rahman KM, Li Y. Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. J Nutr. 2003;133:2434S–9S.

    PubMed  CAS  Google Scholar 

  20. Tewari M, Krishnamurthy A, Shukla HS. Predictive markers of response to neoadjuvant chemotherapy in breast cancer. Surg Oncol. 2008;17:301–11.

    Article  PubMed  Google Scholar 

  21. Lai Y, Yip GW, Bay BH. Targeting metallothionein for prognosis and treatment of breast cancer. Recent Pat Anticancer Drug Discov. 2011;6:178–85.

    Article  PubMed  CAS  Google Scholar 

  22. Lv YG, Yu F, Yao Q, et al. The role of survivin in diagnosis, prognosis and treatment of breast cancer. J Thorac Dis. 2010;2:100–10.

    CAS  Google Scholar 

  23. Papademetriou K, Ardavanis A, Kountourakis P. Neoadjuvant therapy for locally advanced breast cancer: focus on chemotherapy and biological targeted treatments’ armamentarium. J Thorac Dis. 2010;2:160–70.

    CAS  Google Scholar 

  24. Rosenfeldt MT, Ryan KM. The multiple roles of autophagy in cancer. Carcinogenesis. 2011;32:955–63.

    Article  PubMed  CAS  Google Scholar 

  25. Yue Z, Jin S, Yang C, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100:15077–82.

    Article  PubMed  CAS  Google Scholar 

  26. Berger AH, Pandolfi PP. Haplo-insufficiency: a driving force in cancer. J Pathol. 2011;223:137–46.

    Article  PubMed  CAS  Google Scholar 

  27. Edinger AL, Thompson CB. Defective autophagy leads to cancer. Cancer Cell. 2003;4:422–4.

    Article  PubMed  CAS  Google Scholar 

  28. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell. 2005;120:159–62.

    PubMed  CAS  Google Scholar 

  29. Oh S, Xiaofei E, Ni D, et al. Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis. Cell Death Differ. 2011;18:452–64.

    Article  PubMed  CAS  Google Scholar 

  30. Kinch G, Hoffman KL, Rodrigues EM, et al. Steroid-triggered programmed cell death of a motoneuron is autophagic and involves structural changes in mitochondria. J Comp Neurol. 2003;457(4):384–403.

    Article  PubMed  CAS  Google Scholar 

  31. Bursch W, Ellinger A, Kienzl H, et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis. 1996;17(8):1595–607.

    Article  PubMed  CAS  Google Scholar 

  32. Hammond EM, Brunet CL, Johnson GD, et al. Homology between a human apoptosis specific protein and the product of APG5, a gene involved in autophagy in yeast. FEBS Lett. 1998;425(3):391–5.

    Article  PubMed  CAS  Google Scholar 

  33. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122(6):927–39.

    Article  PubMed  CAS  Google Scholar 

  34. Rochaix P, Krajewski S, Reed JC, et al. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis. J Pathol. 1999;187(4):410–5.

    Article  PubMed  CAS  Google Scholar 

  35. Liu M, Lawson G, Delos M, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head Neck. 2003;25(4):280–8.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Vascular and Endocrine Surgery, Xijing Hospital, Fourth Military Medical University, No. 127, Changle West Road, Xi’an, 710032, Shaanxi Province, China

    Qing Yao, Jianghao Chen, Yonggang Lv, Ting Wang, Juliang Zhang, Jing Fan & Ling Wang

Authors
  1. Qing Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jianghao Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yonggang Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ting Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juliang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ling Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ling Wang.

Additional information

Q.Y. and J.C. contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yao, Q., Chen, J., Lv, Y. et al. The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumor Biol. 32, 1163–1171 (2011). https://doi.org/10.1007/s13277-011-0219-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-011-0219-9

Keywords

Search

Navigation